Task Force for Combating Antibiotic-Resistant Bacteria (CARB)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, ASPR
|
NIAID
|
2014
|
|
Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS
|
NCATS, NCCIH, NHLBI, NIAID, NICHD, NIDDK, NIMH, OD/ DPCPSI/ ORWH
|
2017
|
|
Technology Transfer Policy Board (TTPB)
|
Other
|
FDA, CDC, Office of General Counsel - OGC
|
OD/ OSP, OD/ OIR, OD/ OER
|
1995
|
|
The Assay Guidance Manual (AGM)
|
Resource Development
|
FDA
|
NCATS
|
2020
|
|
The Effect of Various Drugs on the Retina
|
Research Initiative
|
FDA
|
NEI
|
2014
|
|
The Epidemiology of Burkitt Lymphoma in East-African Children and Minors (EMBLEM)
|
Research Initiative
|
CDC, FDA
|
NHGRI, NHLBI
|
2010
|
|
The Impact of Tobacco Use on Oral Health and the Oral Microbiome
|
Research Initiative
|
CDC, FDA
|
|
2012
|
|
The MDEpiNet TMJ RoundTable
|
Meeting/ Workshop
|
AHRQ, FDA
|
|
2016
|
|
The Nanoscale Science, Engineering, and Technology (NSET) Subcommittee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ATSDR
|
OD/ OSP
|
2001
|
|
The Nutiriton Research Coordinating Committee (NRCC)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, ASPE, CDC, FDA, HRSA, OASH
|
|
1975
|
|
The President's Task Force on Environmental Health risks and Safety risks to children; Asthma Disparities working group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, IHS
|
NIAID, NICHD, NIMHD, NINR
|
2012
|
|
The Serological Sciences Network (SeroNet)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC, ASPR
|
NIAID, NCI, CC
|
2010
|
|
Tissue Chip Testing Centers (TCTC)
|
Research Initiative
|
FDA
|
NCATS
|
2016
|
|
Tobacco and Nicotine Research Interest Group (TANRIG)
|
Committee, Advisory Group, or Work Group
|
CDC, SAMHSA, FDA, CMS
|
FIC, NCI, NEI, NHGRI, CSR, NCCIH, NIAMS, NIMH
|
2003
|
|
Tobacco Centers of Regulatory Science (TCORS)
|
Research Initiative
|
FDA
|
|
2013
|
|
Tobacco Product Disease Risks
|
Research Initiative
|
FDA
|
|
2016
|
|
Tobacco Regulatory Science Program (TRSP)
|
Research Initiative
|
FDA
|
CSR, NCI, NHLBI, NIAAA, NICHD, NIDA, NIEHS, OD/ OER
|
2012
|
|
Tobacco Use Supplement to Current Population Survey (TUS-CPS)
|
Health Survey
|
CDC, FDA
|
NCI, NIMHD
|
1992
|
|
Toxicology in the 21st Century (Tox 21)
|
Resource Development
|
FDA
|
NCATS, NIEHS
|
2008
|
|
Toxicology in the 21st Century Federal Consortium (NTP NCATS Interagency Agreement, ES-7020-01, Year 11) (Tox21)
|
Research Initiative
|
FDA
|
NIEHS, NCATS
|
2007
|
|
Toxin Working Group of the Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2015
|
|
Toxins Assessment Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, CDC, FDA
|
NIAID
|
2019
|
|
Tracking Resistance and Coronavirus Evolution (TRACE)
|
Resource Development
|
ASPR, CDC, FDA
|
NIAID
|
2021
|
|
Trans-Agency (Medical) Imaging Phantom (TAIP) Workgroup
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIBIB
|
2021
|
|
Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2009
|
|
|